
In the sub-analysis of the CABANA trial (n = 1423), catheter ablation significantly lowered AF recurrence (OR 0.56, p < 0.001) versus drug therapy. Although MR did not affect mortality outcomes, patients with MR showed greater improvements in functional status and MR severity post-ablation. These results suggest ablation may offer structural benefits beyond rhythm control.
Like
Save
Share